Stimulant Medication Treatment in Children with Congenital Heart Disease and Attention-Deficit/Hyperactivity Disorder: Cardiovascular Outcomes

*Division of Growth and Development, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, and King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Bangkok, Thailand;

†Center of Excellence for Maximizing Children's Developmental Potential, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand;

‡Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH;

§Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;

¦Division of Cardiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; and

¶Division of Developmental and Behavioral Pediatrics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Address for reprints: Julia S. Anixt, MD, Division of Developmental and Behavioral Pediatrics, Cincinnati Children's Hospital, 3333 Burnet Avenue, MLC-4002 Cincinnati, OH 45229; e-mail: [email protected].

The authors declare no conflict of interest.

See the Video Abstract at www.jdbp.org

留言 (0)

沒有登入
gif